[
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
    "summary": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=81ac051098960b587eae241299401058d69a13f9ecd3cb362af75030aa9385f8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747674540,
      "headline": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
      "id": 134677211,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=81ac051098960b587eae241299401058d69a13f9ecd3cb362af75030aa9385f8"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues",
    "summary": "Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.",
    "url": "https://finnhub.io/api/news?id=27874ba5d3560e80b1a130546010c80e59947a6280f26a6ee9f645a07acc4ffc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747660380,
      "headline": "ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues",
      "id": 134601686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.",
      "url": "https://finnhub.io/api/news?id=27874ba5d3560e80b1a130546010c80e59947a6280f26a6ee9f645a07acc4ffc"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Q1 Earnings Call: Revenue Tops Expectations, Guidance Lowered Amid Tariff and Integration Headwinds",
    "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=1da3e850538ff8ae4ff4e7c16452dcac835b840ff0f2fb9ae4eb04e03881c764",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747651612,
      "headline": "ZBH Q1 Earnings Call: Revenue Tops Expectations, Guidance Lowered Amid Tariff and Integration Headwinds",
      "id": 134577700,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=1da3e850538ff8ae4ff4e7c16452dcac835b840ff0f2fb9ae4eb04e03881c764"
    }
  }
]